Step by Stepa HemeOncBuddy patient portal

Elranatamab

Illustration: Elranatamab

Say it: el-ran-AT-ah-mab · Brand names: Elrexfio

Elranatamab is an immunotherapy medicine that links your immune cells to myeloma cells so your body can attack the cancer.

What it is

It is a special antibody with two arms. One arm grabs a protein called BCMA on myeloma cells, and the other arm grabs a protein called CD3 on your T cells (a type of immune cell). This brings your immune cells right next to the cancer so they can attack it.

Often used for

How you get it

You get elranatamab as a shot under the skin. The first 2 doses are smaller step up doses, and you stay in the hospital for a time after each one. After that, most people get it once a week, and some can switch to every 2 weeks later on. Your schedule may be different.

Common side effects and what helps

Call your care team right away if you have

Before you start, tell your team

Good to know

At home

Questions to ask

Side effect guides

Sources

Quick answers

What is Elranatamab?
Elranatamab is an immunotherapy medicine that links your immune cells to myeloma cells so your body can attack the cancer. Brand names: Elrexfio.
What is Elranatamab used for?
multiple myeloma that has come back or stopped responding after several other treatments.
How is Elranatamab given?
You get elranatamab as a shot under the skin. The first 2 doses are smaller step up doses, and you stay in the hospital for a time after each one. After that, most people get it once a week, and some can switch to every 2 weeks later on. Your schedule may be different.
What are the common side effects of Elranatamab?
Fever, often from cytokine release syndrome. Feeling tired. Redness or soreness where the shot was given. Diarrhea or nausea. Colds, chest infections, and other infections. Muscle or bone pain. Lower appetite. Rash.
When should I call my care team while taking Elranatamab?
Fever, chills, fast heartbeat, dizziness, or trouble breathing (possible signs of cytokine release syndrome, a strong immune reaction); Confusion, trouble speaking or writing, shaking, very bad sleepiness, seizures, or feeling not like yourself; A fever of 100.4 degrees Fahrenheit (38 degrees Celsius) or higher; Cough, burning when you pee, or other signs of infection; Yellow skin or eyes, or dark urine; Bleeding or bruising that is not normal for you.

Last updated: 2026-10-27. Medically reviewed by Veli Bakalov, MD, medical oncologist (October 2026). General education from Step by Step, the patient portal of HemeOncBuddy.